Sandhya Yadav

Sandhya Yadav

Auto-generated profile, based on publicly available information

Sandhya Yadav

Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
ASAkanksha Srivastava
Akanksha Srivastava
SBSubhankar Biswas
Subhankar Biswas
SYSandhya Yadav
Sandhya Yadav
SKSanjiv Kumar
Sanjiv Kumar
VSVaibhav Srivastava
Vaibhav Srivastava
YMYogesh Mishra
Yogesh Mishra

28 October 2024
Verified
Book Chapter
Closed access
PDF file
SYSandhya Yadav
Sandhya Yadav
MTManish Kumar Tripathi
Manish Kumar Tripathi
Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterised by the progressive loss of dopamine (DA) neurotransmitter-producing neurons in the substantia nigra pars compacta area of the midbrain. Death of DA neurons results in motor deficits and cognitive impairment, which leads to reduced quality of life. Understanding the pathophysiology of PD and developing effective therapeutic strategies is of paramount importance. Investigating the etiology and developing effective therapies for PD necessitates the utilisation of robust animal models that faithfully recapitulate the pathophysiological features of the disease. Among these, chemical-induced/toxin-induced models have emerged as invaluable tools for dissecting the underlying mechanism and evaluating potential therapeutic interventions. This chapter of the book explores different models of PD generated by chemicals/toxins, offering a comprehensive examination of their individual strengths and weaknesses. These contain a variety of neurotoxins, such as 6-hydroxydopamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, rotenone, and 1,1'-dimethyl-4-4'-bipyridinium dichloride, lipopolysaccharides etc. Each of these chemicals/neurotoxins has its unique neurochemical targets and mechanism of action. By conducting a thorough analysis, we want to elucidate the merits and demerits of these toxin models in accurately reproducing fundamental clinical characteristics of PD, including the aggregation and deposition of α-synuclein, aberrant increase of oxidative stress, and increased neuroinflammation. This book chapter is a significant asset for researchers and clinicians involved in PD research. It provides a thorough examination of chemical/toxins-induced PD models and their role in enhancing our knowledge of this neurodegenerative condition. <!----> <!----> <!----> <!---->


7 January 2026 in Nature
Verified
Journal Article
Closed access
SYSandhya Yadav
Sandhya Yadav
TTTara TeSlaa
Tara TeSlaa

21 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SYSandhya Yadav
Sandhya Yadav
TSTapan Sharma
Tapan Sharma
TPTeresita Padilla-Benavides
Teresita Padilla-Benavides
AIAnthony N. Imbalzano
Anthony N. Imbalzano
The transcriptional control of skeletal muscle differentiation requires the coordinated activity of lineage-defining transcription factors, signal-responsive regulators, chromatin modifiers, and ATP-dependent chromatin remodeling enzymes. Here, we identify TCEAL7, a member of the X-linked, poorly characterized TCEAL family of proteins, as a direct downstream target of BRG1-containing mammalian SWI/SNF (mSWI/SNF) complexes and calcineurin signaling during myoblast differentiation. Analyses of previously published datasets showed that pharmacological inhibition of mSWI/SNF bromodomains or knockdown of the BRG1 ATPase, but not knockdown of the homologue BRM ATPase, significantly reduced Tceal7 expression in differentiating C2C12 myoblasts. We demonstrate that BRG1 occupancy at the Tceal7 promoter increased during differentiation, paralleling the induction of Tceal7 expression and nuclear accumulation of TCEAL7 protein. BRG1 functions in part by integrating calcium-dependent cues via the phosphatase calcineurin (Cn); we also determined that Cn knockdown or pharmacological inhibition of Cn suppressed Tceal7 expression and impaired myoblast differentiation. The data suggest that both BRG1-driven chromatin remodeling and Cn signaling converge on Tceal7 regulation. Functionally, Tceal7 knockdown altered cell proliferation and disrupted myoblast differentiation, at least in part due to reduced expression of Myogenin , which encodes a transcription factor that is an essential differentiation determinant. RNA-seq analysis revealed broad dysregulation of myogenic, metabolic, and cell-cycle gene programs in Tceal7 -deficient cells, including changes in cyclin-dependent kinase-regulated pathways consistent with prior reports linking TCEAL7 to cell-cycle control. Together, these findings identify TCEAL7 as a necessary component of the myogenic regulatory network whose expression is controlled by BRG1-dependent chromatin remodeling and Cn activity.